These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 1367057)
41. Molecular analysis of mutations induced by chemical carcinogens in mammalian cells. II. The use of recombinant DNA vectors. Basic-Zaninovic T; Palombo F; Calcagnile AS; Dogliotti E Ann Ist Super Sanita; 1994; 30(2):191-9. PubMed ID: 7832410 [TBL] [Abstract][Full Text] [Related]
42. Replicating foamy virus-based vectors directing high level expression of foreign genes. Schmidt M; Rethwilm A Virology; 1995 Jun; 210(1):167-78. PubMed ID: 7793069 [TBL] [Abstract][Full Text] [Related]
43. Engineering mRNA translation initiation to enhance transient gene expression in chinese hamster ovary cells. Underhill MF; Coley C; Birch JR; Findlay A; Kallmeier R; Proud CG; James DC Biotechnol Prog; 2003; 19(1):121-9. PubMed ID: 12573014 [TBL] [Abstract][Full Text] [Related]
44. Engineering mammalian cell factories for improved recombinant monoclonal antibody production: lessons from nature? Dinnis DM; James DC Biotechnol Bioeng; 2005 Jul; 91(2):180-9. PubMed ID: 15880827 [TBL] [Abstract][Full Text] [Related]
45. [Development of site-specific integration system to high-level expression recombinant proteins in CHO cells]. Zhou H; Liu ZG; Sun ZW; Yu WY Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):756-62. PubMed ID: 17822058 [TBL] [Abstract][Full Text] [Related]
46. Production and analysis of proteins by recombinant DNA technology. Pestka S Bioprocess Technol; 1990; 7():235-65. PubMed ID: 1366823 [No Abstract] [Full Text] [Related]
47. Methods in mammalian cell line engineering: from random mutagenesis to sequence-specific approaches. Krämer O; Klausing S; Noll T Appl Microbiol Biotechnol; 2010 Sep; 88(2):425-36. PubMed ID: 20689950 [TBL] [Abstract][Full Text] [Related]
48. Development of new cell lines for animal cell biotechnology. MacDonald C Crit Rev Biotechnol; 1990; 10(2):155-78. PubMed ID: 2202521 [TBL] [Abstract][Full Text] [Related]
49. Expression and export: recombinant protein production systems for Aspergillus. Fleissner A; Dersch P Appl Microbiol Biotechnol; 2010 Jul; 87(4):1255-70. PubMed ID: 20532762 [TBL] [Abstract][Full Text] [Related]
50. Production of recombinant proteins and metabolites in yeasts: when are these systems better than bacterial production systems? Porro D; Gasser B; Fossati T; Maurer M; Branduardi P; Sauer M; Mattanovich D Appl Microbiol Biotechnol; 2011 Feb; 89(4):939-48. PubMed ID: 21125266 [TBL] [Abstract][Full Text] [Related]
51. Identifying and engineering promoters for high level and sustainable therapeutic recombinant protein production in cultured mammalian cells. Ho SC; Yang Y Biotechnol Lett; 2014 Aug; 36(8):1569-79. PubMed ID: 24737078 [TBL] [Abstract][Full Text] [Related]
52. Mammalian cell culture at the University of New South Wales. Gray PP; Marsden WL; Crowley J; Gebert C; Jirasripongpun K; Lovrecz G; Mitchell C; Mahler SM Aust J Biotechnol; 1990 Apr; 4(2):121-3, 134. PubMed ID: 1366644 [No Abstract] [Full Text] [Related]
53. Protein secretion systems in microbial and mammalian cells. Moir DT; Mao JI Bioprocess Technol; 1990; 9():67-94. PubMed ID: 1366891 [TBL] [Abstract][Full Text] [Related]
54. [Genetically engineered drugs and their application with the example of erythropoietin]. Donatz V; Zahner J Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):440-4. PubMed ID: 11496621 [TBL] [Abstract][Full Text] [Related]